Tekla Life Sciences Investors (HQL)
USD 13.34
(-3.82%)
USD 13.34
(-3.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 23.52 Million | -103.25 Million | 65.68 Million | 124.08 Million | -69.34 Million | 29.82 Million |
| Cost of Revenue | 5.24 Million | 5.54 Million | 6.07 Million | 5.2 Million | 5 Million | 4.77 Million |
| Gross Profit | 18.27 Million | -108.79 Million | 59.61 Million | 118.87 Million | -74.34 Million | 25.05 Million |
| Operating Expenses | 23.52 Million | 1.35 Million | 1.15 Million | 1.02 Million | 1.13 Million | 1.15 Million |
| Selling, General and Administrative Expenses | 903.13 Thousand | 1.07 Million | 844.01 Thousand | 751.31 Thousand | 876.76 Thousand | 880.75 Thousand |
| Research and Development Expenses | - | -3.28 | 1.43 | 3.15 | -1.84 | 0.80 |
| Other Expenses | 22.62 Million | 275.96 Thousand | 313.68 Thousand | 278.66 Thousand | 259.75 Thousand | 466.64 Thousand |
| Cost and Expenses | 23.52 Million | 1.35 Million | 1.15 Million | 1.02 Million | 1.13 Million | 5.59 Million |
| Operating Income | -5.24 Million | -104.6 Million | 64.53 Million | 123.05 Million | -70.47 Million | -3.6 Million |
| Interest Expense | - | - | - | - | - | 32.27 Million |
| Income Tax Expense | - | -2.98 Million | -4.14 Million | -2.12 Million | -2.88 Million | 1.00 |
| Earnings before Tax | 22.35 Million | -104.6 Million | 64.53 Million | 123.05 Million | -70.47 Million | 28.66 Million |
| Net Income | 22.35 Million | -104.6 Million | 64.53 Million | 123.05 Million | -70.47 Million | 28.66 Million |
| Earnings Per Share Basic | 0.83 | -4.07 | 2.66 | 5.16 | -3.04 | 1.28 |
| Earnings Per Share Diluted | 0.83 | -4.07 | 2.66 | 5.16 | -3.04 | 1.23 |
| Weighted Average Shares Outstanding | 26.79 Million | 25.67 Million | 24.25 Million | 23.84 Million | 23.17 Million | 22.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.79 Million | 25.67 Million | 24.25 Million | 23.84 Million | 23.17 Million | 23.3 Million |
| Gross Margin | 0.78 | 1.05 | 0.91 | 0.96 | 1.07 | 0.84 |
| EBIT Margin | 0.95 | 1.01 | 0.98 | 0.99 | 1.02 | 2.04 |
| Profit Margin | 0.95 | 1.01 | 0.98 | 0.99 | 1.02 | 0.96 |
| EBITDA | 22.35 Million | -104.6 Million | 64.53 Million | 123.06 Million | -70.47 Million | 28.66 Million |
| Earnings Before Tax Margin | -0.22 | 1.01 | 0.98 | 0.99 | 1.02 | -0.12 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.03 Million | 1.03 Million | 29.56 Million | 23.52 Million | 9.82 Million | 964.63 Thousand |
| Cost of Revenue | 2.53 Million | - | 2.59 Million | 5.24 Million | 2.65 Million | - |
| Gross Profit | -1.49 Million | 1.03 Million | 26.97 Million | 18.27 Million | 7.16 Million | 964.63 Thousand |
| Operating Expenses | 1.35 Million | 24.09 Million | 38.42 Million | 1.17 Million | 15.93 Million | 15.93 Million |
| Selling, General and Administrative Expenses | 1.35 Million | 1.35 Million | - | - | 1.43 Million | 1.43 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 53.01 Million | - | -38.42 Million | -11.78 Million | 26.63 Million | - |
| Cost and Expenses | 1.35 Million | 24.09 Million | 41.01 Million | 1.17 Million | -23.98 Million | 15.93 Million |
| Operating Income | -326.66 Thousand | -326.66 Thousand | -11.44 Million | 22.35 Million | 33.8 Million | -470.37 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -326.66 Thousand | 25.45 Million | -43.81 Thousand | 22.35 Million | -470.37 Thousand | 17.37 Million |
| Earnings before Tax | 25.12 Million | 25.12 Million | -11.45 Million | 22.35 Million | 33.8 Million | 16.9 Million |
| Net Income | 25.12 Million | 25.12 Million | -11.45 Million | 22.35 Million | 33.8 Million | 16.9 Million |
| Earnings Per Share Basic | 0.92 | 0.92 | -0.43 | - | 1.29 | 0.64 |
| Earnings Per Share Diluted | 0.92 | 0.92 | -0.43 | - | 1.29 | 0.64 |
| Weighted Average Shares Outstanding | 27.35 Million | 27.35 Million | 26.79 Million | 26.79 Million | 26.21 Million | 26.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.35 Million | 27.35 Million | 26.79 Million | 26.79 Million | 26.21 Million | 26.21 Million |
| Gross Margin | -1.45 | 1.00 | 0.91 | 0.78 | 0.73 | 1.00 |
| EBIT Margin | 24.65 | 24.65 | -0.39 | - | 3.44 | 18.01 |
| Profit Margin | 24.33 | 24.33 | -0.39 | 0.95 | 3.44 | 17.52 |
| EBITDA | 25.45 Million | 25.45 Million | -11.44 Million | - | 33.8 Million | 17.37 Million |
| Earnings Before Tax Margin | -0.32 | -0.32 | -0.39 | 0.95 | 3.44 | -0.49 |
SOFTSOL
4DS
NODK
ALTPC
002370
0M0Q